Stem cell transplant: Insurance company told to reimburse Rs 4 lakh to liver cirrhosis patient

An insurance company has been ordered to reimburse ₹4 lakh for a stem cell transplant to a liver cirrhosis patient. This ruling, likely by a consumer court or ombudsman, provides significant relief to the patient, ensuring coverage for a crucial medical procedure. The decision indicates that the insurance company's initial rejection of the claim was found to be unjustified, possibly due to misinterpretation of policy terms or a lack of proper consideration. This case underscores the importance of comprehensive health insurance coverage and the recourse available to policyholders against arbitrary claim denials, promoting consumer protection in healthcare.